Neuland Laboratories Limited

NEULANDLAB.NS·NSE·Healthcare
Compare
18,975.00−245.00 (−1.27%)today
At close: Oct 21, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close19,220.00
Open19,220.00
Day range18,500.0019,380.00
52-week range11,500.0024,225.00
Off day high−2.09%
Off 52-week high−21.67%
Volume60.54K
Avg. volume (3M)65.33K
Market cap243.45B
EPS (TTM)387.97
Forward P/E39.09
P/E ratio (TTM)48.91
Dividend yield0.18% (34.00)
Beta (5Y)0.28
Shares outstanding12.83M
Short interest—
Earnings dateJul 30, 2025 (est.)
Analyst target24,678.50
Profit margin20.99%

Against its peers

Compare in full ›
NEULANDLAB.NS 000078.SZ ALKEM.NS IPCALAB.BO NATCOPHARM.NS APLLTD.BO
Market cap 243.45B 3.55B 599.62B 486.30B 144.34B 154.92B
P/E (TTM) 48.9 — 27.8 37.1 12.4 22.3
Forward P/E 39.1 4.2 22.4 27.2 16.6 16.1
Price/book 13.0 3.5 4.3 6.0 1.5 2.7
Dividend yield 0.18% — 0.40% 0.33% 0.74% 1.52%
1-year change +18.15% −45.49% −9.58% +42.49% −4.89% −15.06%
Today −1.27% −2.88% +0.22% +5.60% −2.05% −0.26%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Kalkine India·

Neuland Laboratories NEULANDLAB US FDA EIR Unit 3 Closed

Neuland Laboratories (NSE:NEULANDLAB): What Does the US FDA's Closed EIR Mean for Unit 3? Kalkine India Neuland Laboratories (NSE:NEULANDLAB): What Does the US FDA's Closed EIR Mean for Unit 3? Source: Krish Capital Pty Ltd Neuland…

From articles in the 4Search news index.

In the news

7mentions in 30 days
7with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.